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ABSTRACT 
 
Genetic alteration on p53 allows cellular immortalization and predisposes cells to neoplastic transformation. 
This immortalization is related to telomere length maintenance by telomerase. Human TERT is a key compo-
nent of telomerase, which activity is suppressed by p53. The p73, the homolog of p53, has a similar ability in 
tumor suppression. The P73 is expressed at a different level in various cancer cells and normal tissues.  Profile 
of human TERT  and P73 in mutant p53 OSCC cell line and normal  human oral mucosa have not been known. 
Objective: To observe human TERT and P73 profile in mutant p53 OSCC cell lines and normal human oral 
mucosa. Methods: The extracted protein of HSC-3 and HSC-4 cell lines and normal mucosal tissues were ana-
lyzed with SDS PAGE to detect human TERT and p73 expression based on the molecular weight. Results: The 
HSC-3 cell line showed thicker band density of P73 compared to its density of HSC-4. Only 50% of normal 
oral mucosa tissue showed thick  P73 band density. The human TERT band was clearly shown in HSC-3 and 
HSC-4 cell lines but not in normal oral mucosa. Conclusion: Different profile of human TERT and P73 in 
OSCC cell lines and normal oral mucosa might be cell-type specific and influenced by the status of p53. Analy-
sis of the role of p73 in these cancers might need further research to determine possible p73 substitution for  
p53 function. 
 
ABSTRAK 
 
Profil hTERT dan P73 pada kultur sel kanker mulut dibandingkan mukosa normal: studi pendahuluan. 
Perubahan genetik pada p53 memungkinkan terjadinya imortalisasi sel dan meningkatkan predisposisi terjad-
inya transformasi ke arah neoplasma. Hal ini terkait dengan aktivitas telomerase yang menjaga panjang te-
lomer, yang aktivitasnya seharusnya dibatasi oleh p53. p73, yang merupakan homolog p53, mempunyai ke-
mampuan supresi tumor yang mirip dengan p53. Tingkat ekspresi P73 dan human TERT kemungkinan berbeda 
pada berbagai jenis sel kanker dibandingkan dengan jaringan normalnya.  Saat ini belum terdapat data tentang 
profil protein human TERT dan P73 pada sel lini karsinoma sel skuamosa oral (KSSO) dibandingkan dengan 
jaringan mukosa oral normal. Tujuan: Studi ini bertujuan untuk mendapatkan profil human TERT dan P73 
pada sel lini KSSO dengan mutasi p53 dibandingkan dengan mukosa oral normal. Metode: Sel lini HSC-3 dan 
HSC-4 dengan mutasi p53 dikultur sedangkan mukosa oral normal dikumpulkan dari pasien tanpa kanker yang 
menjalani perawatan bedah mulut. Ekstraksi protein dan analisis profil human TERT dan P73 dilakukan den-
gan SDS-PAGE dan ditentukan berdasarkan perkiraan berat protein. Hasil: Pita human TERT jelas terlihat 
pada sel HSC-3 dan HSC-4 namun tidak pada mukosa oral normal. Densitas pita P73 pada sel HSC-3 terlihat 
lebih tebal dibandingkan pada sel HSC-4. Hanya 50% sampel mukosa oral normal memperlihatkan pita P73. 
Simpulan: Terlihat profil human TERT dan P73 yang berbeda pada sel kanker dan sel normal. Perbedaan ini 
kemungkinan bersifat spesifik tergantung jenis sel dan dipengaruhi oleh status p53. Perlu dilakukan penelitian 
lanjutan untuk menganalisis kemungkinan peran p73 dalam menggantikan fungsi p53 pada kanker mulut selan-
jutnya diperlukan.  
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Figure 1. Phase contrast photomicrographs of the HSC-3 cell line (A) and HSC-4 cell line (B) after 2 days culture 
(Original magnification x10) 
INTRODUCTION 
 
The p53 is the most common tumor suppression gene 
mutated in oral squamous cell carcinoma (OSCC) 
with the frequency of 50% cases.1 It functions as  
activator of transcription process, DNA repair, apop-
tosis, senescence, cell cycle regulator, and suppress 
activities of several genes, one of them is hTERT.1,2 
The hTERT encodes 7 protein isoforms, with human 
TERT acts as the key component that control the 
activity of telomerase.3,4 Telomerase is defined as 
enzyme that can lengthen DNA by adding telomere 
repeat at the chromosome ends.5 Telomerase presents 
on most cancer cells.6 Several transcription factors, 
including oncogene and tumor suppressor genes 
(TSG) could influence the hTERT transcription. In-
activation of p53 plays a role in hTERT activation on 
carcinogenesis, through the alteration from normal 
cells with negative telomerase into cancer cells with 
positive telomerase.7 
 
In 1997, the human homolog of p53, called p73 was 
identified.8 The p73 shares more than 60% similari-
ties of amino acid as in p53 DNA binding region, 
including conservation of all DNA contact and struc-
tural residues that become the most frequent location 
of p53 mutation in tumor.9 In the other hand, p73 
shared 58% similarities with p53 tetramerization 
domain and 29% similarities with p53 transactivation 
(TA) domain.9 In contrast to p53, mutation of p73 
only occurred in less than 0.5% of cancers.10,11 Even 
though p73 mutation is rare, the expression and func-
tion of different p73 isoforms are clearly altered in 
certain cancers. The P73 had a complexitivity on its 
protein isoforms because of the use of  alternative 
promoter and differential mRNA splicing. There are 
two variants of P73 with a difference at its N-
terminus, which comes from the utilization of two 
different p73 promoter.12,13 
Data regarding p73 mutation has not been available 
in the literature, however different roles of several 
isoforms of p73 as tumor suppressor gene with anti-
apoptosis effect (TAP73) and as oncogene (∆NP73) 
have been elucidated.6,7 It has also been shown the 
correlation between tumor stage and the level of p73 
expression. Studies on oral cancer have shown ten-
dency of increased telomerase activity that was in 
concordance with the progression of carcinogene-
sis.8,9 Therefore, changes in the expression pattern of 
human TERT would be expected.12,13 Data showing 
correlation between p73 expression in tumors with 
different status of p53 mutation and telomerase ac-
tivity would be important to give basis for further 
study that investigate the actual main isoform of p73 
involved.   
 
 
METHODS 
 
OSCC cell lines type HSC-3 and HSC-4 were cul-
tured on high glucose DMEM (GIBCO) supple-
mented with 10% FBS along with 100iu/ml Penicil-
lin Streptomycin (GIBCO) and 2.5 μg/ml Fungizone 
(GIBCO), then incubated at 37oC, 95% humidity 
with 5% CO2 (Figure 1). After 90% confluency was 
reached, the cells were harvested with 0.02% tryp-
sin/0.25% EDTA (JRH Biosciences) and subjected 
to protein extraction.  This study used 4 to 5 culture 
plates of the HSC-3 and HSC-4 cell lines for analysis 
of the protein profile.  
 
Fourteen dental patients without HNSCC or other 
malignancy, who were undergoing minor oral sur-
gery in the Departments of Oral and Maxillofacial 
Surgery or periodontal surgery in the Faculty’s Den-
tal Hospital, gave their approval to participate in the 
study. Control tissue was obtained from the gingival 
or adjacent oral mucosa involved in the removal of 
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teeth or hyper plastic gingival tissue removed in 
periodontal surgery. This tissue was further stated as 
normal human oral mucosa (NHOM) in this study. 
 
Extraction of protein from HSC-3, HSC-4 cell lines, 
and normal human oral mucosa was performed by 
using Kit TRIzol (Invitrogen) following instruction 
from the manufacturer. Bradford Protein Assay was 
performed to quantify total protein concentration of 
each sample. Analysis of protein used SDS PAGE to 
observe the samples protein profiles based on its 
molecular weights. SeeBluePlus2 (Invitrogen) pro-
tein molecular weight marker was used in this study. 
This marker consists of 10 protein with molecular 
weight ranged from 3 to 188kDa. The gels obtained 
was stained with 0.05% Comassie Blue. The protein 
profiles and shown as dark bands running at a lane 
within the gels after staining. The resulting protein 
profiles had molecular weight ranging from 14 to 
188kDa. 
 
The gels were further analysed for semi quantitative 
assessment of bands intensity using Gel Doc 2000 
with Quantity One (BioRad) program. The gels were  
captured with white light mode. This mode was used 
for samples that can reflect and scatter lights. Using 
this mode, data was measured in uncalibrated optical 
density (uOD) units. The higher the uOD, the higher 
the opacity. The gels’ ability to reflect the light 
would be assumed as protein bands with a certain 
minimal densities. The minimal densities used in this 
research were based on Quantity One program’s ini-
tial assembly. The gel’s bands in certain sites were 
compared with protein standard’s band to estimate 
the exact protein molecular weights.21 The protein 
marker used is SeeBluePlus2 (Invitrogen) that has 
effectively determined molecular weight between 3 
to 188kDa in SDS PAGE.  
 
 
RESULTS 
 
The human TERT and P73 expression was presented 
visually as band with different densities according to 
the molecular weight marker. There are five visual 
categories used to grade the protein expression based 
on protein bands densities. This study categorized 
the bands to be very thick, medium,   thin,   and  very  
thin.  On  SDS PAGE, P73 protein that had 90kDa 
molecular weight was estimated to be located be-
tween 70 to 117kDa. Meanwhile the hTERT protein 
that had 127kDa molecular weight, was estimated to 
be located between the 117 and 137kDa. After co-
massie blue staining, the gels were further analyzed 
using Gel Doc 2000 and Quantity One (BioRad) 
program was used to determine the more accurate 
protein samples molecular weight. The data obtained 
from this program were measured in uncalibrated 
optical density (uOD) units. The gel’s bands in cer-
tain sites were compared with protein marker band as 
a standard to estimate the exact protein molecular 
weight, so the more accurate protein molecular 
weight can be detected and compared with visual 
observation. 
 
This study might have detected the human TERT 
(127kDa) estimated to be located between 117 and 
137kDa bands in the gels. Relatively low band inten-
sities of suspected human TERT were showen 
(Figure 2). The human TERT were detected in 4 
repeated samples of HSC-4 cell lines, however den-
sity of the bands was not similar between repeated 
samples (Figure 2A). Similarly, different band densi-
ties (ranging from medium to thin density) were also 
showed in the five repeated samples of HSC-3 cell 
line (Figure 2B). Thin band of human TERT was 
shown (Figure 2A) in 2 out of 14 of NHOM samples 
(Figure 2A).  The suspected P73 was expressed in 
HSC-3 and HSC-4 cell lines and normal human oral 
mucosa (Table 1). All repeated samples of HSC-3 
cell line showed thick bands of P73 (Figure 2A). 
Different band intensities were found in 4 repeated 
samples of HSC-4 cell line ranging from medium to 
thin bands. Results of that in NHOM (n=14) were 
more variably shown. Strong protein bands of the 
p73 showed in 8 out of 14 NHOM samples and 5 out 
of 14 samples were presented as  medium bands 
(Table 1). Overall, expression of the human TERT 
was relatively lower compared to that of P73 in both 
HSC-3 and HSC-4 cell lines. However, when the 
P73 expression was compared between the two cell 
lines, the HSC-3 cell line showed relatively higher 
level of p73 expression compared to HSC-4 cell line. 
While only 2 out of 14 of NHOM showed medium 
level of human TERT, all NHOM samples showed 
strong P73 bands.  
 
 
DISCUSSION 
 
The SeeBluePlus2 (Invitrogen) protein molecular 
weight marker consist of ten protein marker bands 
and has an ability to estimate protein molecular 
weight within 3-188kDa on SDS PAGE gel after 
comassie blue staining. However, some problems 
were found when determining the human TERT mo-
lecular weight using this protein marker. Based on 
this protein marker, the human TERT which had 
127kDa molecular weight should be located within 
117kDa and 137kDa protein bands. It was difficult to 
visually observe the human TERT bands between 
those very close protein markers with such a consid-
erable molecular weight disparity. The determination 
was further need the usage of Quantity One (BioRad) 
Program. The suspected human TERT presented in 
HSC-3 and HSC-4 cell lines was consistent with 
many literatures that most of cancer cells had a te-
lomerase activity that affected by hTERT gene.6 Mu-
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Figure 2. SDS PAGE gel (upper panel) and semi quantitave analysis of bands intensity using Gel Doc 2000 (lower 
panel). Approximate location of human TERT at 127kDa (grey arrow) and P73 at 90kDa (black arrow), A. (1) Molecular 
weight marker (kDa) SeeBluePlus2 (Invitrogen), (2)-(5) HSC-4, (6)-(8) NHOM samples.  B. (1) Molecular weight 
marker (kDa) SeeBluePlus2 (Invitrogen), (2)-(8) HSC-3.  
Table 1. Presence and level of expression of P73 protein on SDS PAGE on HCS-3, HSC-4 and NHOM samples 
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Figure 3. Schematic diagram of exon structure of p53 and p73. The region of transactivation domain (TAD), DNA-
binding domain (DBD) and the oligomerization domain (OD) are shown in grey. Sterile alpha motif (SAM). Numbers of 
exons are indicated in Roman letters above the full length protein. The number of exon spliced out in each isoform are 
shown on the right. (*) indicate the isoform that only described in mouse.17  
tation in p53 gene causing mutant form of p53 could 
not run its normal function as human TERT suppres-
sor.7 The HSC-3 and HSC-4 cell lines were known 
as a p53 mutated cancer cells. Unlike cancer cells, 
telomerase activity is usually not presents in normal 
somatic cells. The presence of human TERT expres-
sion in normal human oral mucosa used in this re-
search was probably because of the occurrence of 
keratinocyte and hematopoietic cells presented in 
blood.14 Keratinocyte cell was the main cell found in 
gingival tissues, meanwhile hematopoietic cell is a 
cell isolated from blood or bone marrow that could 
renews itself and differentiates into many variable 
cells.15,16 
 
Based on the literature, each proteins and isoforms 
from P73 expressed at different levels, depends on 
the tissue types and the development stages.17,18 The 
p73 expression in cancer was very variable and some 
cell lines and primary tumor cells expressed P73 at 
the easily detected level.18 According to the data 
obtained, the P73 was detected at all HSC-3 and 
HSC-4 cell lines. The P73 was also detected in most 
of the human oral mucosal samples observed. The 
intensity of the P73 expression was determined 
based on protein bands density approximately at 
90kDa molecular weight presented at SDS PAGE. 
The expression of P73 exhibits an active gen activ-
ity. Observation on SDS PAGE gel showed that HSC
-3 had a higher P73 expression than HSC-4. The 
HSC-3 and HSC-4 cell lines have different property 
in p53 mutation. In HSC-3, there is the insertion of 4 
base pair TAAG at codon 305-306 and has a SNP 
72P (coding proline) and the cell line does not pro-
duce P53. Meanwhile in HSC-4, there is missense 
mutation at codon 248 and had SNP 72R (coding 
arginine) and the cell line produces mutant p53.18-20 
The result of this study showed higher level of P73 
in HSC-3 than in HSC-4 cell lines. It might be re-
sulted from the fact that there is no p53 in HSC-3, 
therefore it was postulated that P73, which had a pro-
apoptosis activity, is expressed in higher level. The 
P73 protein might act to compensate the function of 
p53 that is reduced or lost in the cell line. These re-
sults might be consistent with the fact that HSC-4 
had a single nucleotide polymorphism at codon 72R 
that encodes arginine. Consequently, p53 mutant is 
more strongly bind to and inactivate p73. However, 
the complexity of p73 need to be considered further, 
since p73 was known to produce some protein iso-
forms by alternative splicing mechanism. One of P73 
products is anti apoptosis molecule. Since p73 is pro- 
and anti-apoptosis proteins concurrently, those rela-
tive expression of both proteins should be put in im-
portance while observing the gene expression at pro-
tein level. There are some tumors that show high P73 
expression and there are some tumors that exhibit 
low P73 expression. This is possible as each of P73 
isoforms had a different effect. This research did not 
separate P73 with a reagent that could distinctly 
separate TA and N form of P73.19,20  
 
In HSC-3 and HSC-4 cell lines, there are p53 muta-
tions exist with different properties. In HSC-3, the 
mutation form is the insertion of 4 base pair TAAG 
at codon 305-306 and has a SNP 72P (coding 
proline) and not producing p53 protein. Meanwhile 
HSC-4 the mutation form is the missense mutation at 
codon 248 and had SNP 72R (coding arginine) and 
producing mutant p53 protein.20 
 
With in situ RT-PCR, hTERT expression was not 
seen in normal epithelium or mild dysplasia, but it 
was detected at moderate dyplasia with higher level 
of histopathology, severe dysplasia, and invasive 
carcinoma. This indicate that the increase of telom-
erase expression  is found  in oral carcinogenesis and 
support telomerase roles in human oral cancer     
development.22 The amount of hTERT transcription 
quantity detected at normal tissue speciments was 
caused by the presence of oral keratinocyte and he-
matopoietic cells that exhibits  a constant telomerase 
activity to undergo cell replication, differentiation 
and regeneration.15,22,23 
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p53 was very low expressed at epithelial cell, while 
P73 was expressed a lot at epithelial   tissues which 
are the location of carcinoma growth. This demon-
strates that P73 had a tissue specialty towards epithe-
lial solid tumor rather than P53.15,22,23 Furthermore, 
P73 has a role in malignant transformation at 
squamous cell carcinoma. Functional loss of P73 was 
related with squamous cell carcinoma. This is be-
cause a transformation from initial into malignant 
stage at mice models was followed by an almost total 
sporadic loss in p73 mRNA and its protein            
expression.12 
 
 
CONCLUSION 
 
It can be concluded that the human TERT found in 
HSC-3 and HSC-4 cell lines is related to the condi-
tion of p53 mutation. In normal human oral mucosa, 
human TERT is likely exposed from actively differ-
entiating and regenerating cells of the tissues. Based 
on the density of protein bands on SDS PAGE, the 
P73 expression in HSC-3 was higher than in HSC-4. 
This might be influenced by the different p53 protein 
level at those cell lines and the interaction strength 
between p73 and mutant p53 with polymorphism at 
codon 72. The HSC-4 cell line which is known as 
p53 mutant with arginine at 72 residue is more 
strongly bind to and inactivate p73. Most of the nor-
mal human oral mucosa samples showed bold P73 
bands that easily observed visually. The expression 
pattern demonstrated is conformed the theory that 
P73 had a specific location of action at the epithelial 
tissues. Further study need to be done to get deeper 
insight on the specific isofroms of P73 that plays role 
in the findings of the current study. 
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